Showing results (1641-1650 of 2,473) with videos related to
Sort By:
Pageof 248
Cancer Treatment Reviews|November 21, 2017
The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic reviewA F de Groot, N M Appelman-Dijkstra, S H van der Burg, et al.Cancer Treatment Reviews|November 21, 2017
PD-1 blockade in advanced NSCLC: A focus on pembrolizumabSolange Peters, Keith M Kerr, Rolf StahelCancer Treatment Reviews|November 10, 2017
The prognostic role of epigenetic dysregulation in bladder cancer: A systematic reviewDavid Casadevall, Anaïs Yacine Kilian, Joaquim BellmuntCancer Treatment Reviews|December 5, 2017
Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup ConsortiumS C Clement, L C M Kremer, F A Verburg, et al.Cancer Treatment Reviews|November 28, 2017
Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in EuropeE J Blok, E Bastiaannet, W B van den Hout, et al.Cancer Treatment Reviews|September 5, 2017
Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategiesMarta Chiaravalli, Michele Reni, Eileen M O'ReillyCancer Treatment Reviews|September 26, 2017
Peripheral T-cell lymphomas: Focusing on novel agents in relapsed and refractory diseaseAlessandro Broccoli, Lisa Argnani, Pier Luigi ZinzaniCancer Treatment Reviews|July 14, 2017
Preinvasive disease of the airwayRicky M Thakrar, Adam Pennycuick, Elaine Borg, et al.Cancer Treatment Reviews|September 6, 2020
Is DNA repair a potential target for effective therapies against malignant mesothelioma?Ilaria Fuso Nerini, Elisa Roca, Laura Mannarino, et al.Cancer Treatment Reviews|November 23, 2020
A basic review on systemic treatment options in WHO grade II-III gliomasMaximilian J Mair, Marjolein Geurts, Martin J van den Bent, et al.Pageof 248